| Mrs Julia Kay Chipman, RN | |
|
41609 Ne Ira Jones Rd, Amboy, WA 98601-3604 | |
| (360) 263-5486 | |
| Not Available |
| Full Name | Mrs Julia Kay Chipman |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 41609 Ne Ira Jones Rd, Amboy, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235378431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 200742946RN (Oregon) | Primary |
| 163W00000X | Registered Nurse | RN00173702 (Washington) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Julia Kay Chipman, RN 41609 Ne Ira Jones Rd, Amboy, WA 98601-3604 Ph: (360) 263-5486 | Mrs Julia Kay Chipman, RN 41609 Ne Ira Jones Rd, Amboy, WA 98601-3604 Ph: (360) 263-5486 |
News Archive
Axxam (Milan), a leading provider of discovery services including assay development for high-throughput screening, and Cellectis bioresearch (Paris), the cell engineering expert, have started a collaboration to offer to the Life Science industry an extensive range of integrated discovery services based on genomic engineering technologies.
Data from the Netherlands indicate that living in close proximity to livestock farms is associated with decreased respiratory morbidity, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease.
Aeterna Zentaris Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration ("FDA") on a Special Protocol Assessment ("SPA") for an upcoming Phase 3 registration trial in endometrial cancer with its doxorubicin peptide conjugate, AEZS-108. The SPA agreement states that the proposed trial protocol design, clinical endpoints and planned analyses are acceptable to the FDA to support a regulatory submission.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Colorado. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
› Verified 2 days ago